Why do some doctors still recommend bedtime dosing?

The recommendation traces to the Hygia Chronotherapy Trial, published in 2019, which reported that bedtime dosing nearly halved cardiovascular events. That result was far larger than anything seen before or since. The European Heart Journal issued an expression of concern in April 2020 and an investigation followed, and larger randomized trials have not reproduced the finding. Guidance in many places has not caught up.

Does taking blood pressure medication at night lower nighttime readings?

It can. The OMAN randomized trial found bedtime dosing produced a greater reduction in nocturnal blood pressure than morning dosing. That is a real physiological effect. The larger outcome trials show it does not translate into fewer heart attacks or strokes, which is a useful reminder that a better number on a monitor is not automatically a better outcome.

Should I take my water pill at night?

Usually not. Diuretics such as hydrochlorothiazide and furosemide increase urine production, and taking them in the evening commonly causes repeated night waking. That disrupts sleep, and in older adults it raises the risk of falls on the way to the bathroom. Morning, or early afternoon for a second dose, is the conventional approach.

Is it safe to switch when I take my blood pressure medication?

For most people on a stable regimen this is a low-risk change, but it is worth confirming with your prescriber or pharmacist first, because it depends on which drugs you take. The main practical caution is avoiding a doubled or missed dose during the switch. Some people also feel lightheaded when a dose lands at a different point in their day.

Is It Better to Take Blood Pressure Medication at Night or in the Morning?

Q: Is it better to take blood pressure medication at night?

For cardiovascular outcomes, no. The TIME trial randomized 21,104 UK adults to evening or morning dosing and found no difference in vascular death, heart attack, or stroke over a median 5.2 years. The BedMed trial, published in JAMA in 2025 with 3,357 Canadian patients, found the same. Consistency matters more than the clock.

This question has produced unusually confident advice in both directions over the last few years, which is a good sign that the evidence was not settled. It is closer to settled now.

Three large randomized trials covering more than 25,000 people have compared bedtime dosing with morning dosing and measured what actually matters: heart attacks, strokes, and deaths. All three found essentially nothing.

The short answer

Take your blood pressure medication at whatever time you will reliably take it every day. For cardiovascular outcomes, morning and bedtime dosing perform the same.

There are a few practical exceptions, mostly about side effects rather than effectiveness: diuretics are usually better in the morning to avoid night-time trips to the bathroom, and a drug that makes you lightheaded may be easier to tolerate at bedtime. Those are comfort and safety decisions, not outcome decisions.

Where did the 'take it at night' advice come from?

The idea has a plausible mechanism behind it. Blood pressure normally falls overnight, a pattern called dipping. People whose pressure fails to dip, or rises overnight, have worse cardiovascular outcomes. So targeting the overnight period with bedtime dosing seemed like it should help.

The evidence that made this mainstream was the Hygia Chronotherapy Trial, published in 2019. It enrolled 19,084 patients with a mean age of 60.5 and reported that bedtime dosing was associated with roughly a halving of the risk of cardiovascular death, heart attack, stroke, and heart failure.

That result was extraordinary. A halving of cardiovascular events from changing the time of day someone swallows an existing pill would be one of the largest effects in modern cardiology, achieved at zero cost.

Effects that large in a single trial usually warrant caution. In April 2020, the European Heart Journal published an expression of concern noting the trial's conduct was under investigation and advising readers to interpret the results cautiously. The investigation concluded there were no grounds for ethical or factual concern, though the editors acknowledged that verifying the source data was outside their scope, and independent methodological criticism has continued.

Rather than relitigate that trial, researchers ran new ones.

What did the TIME trial find?

TIME is the largest test of the question and it is decisive in its scale.

Published in The Lancet in 2022, it randomized 21,104 UK adults with hypertension to take their usual antihypertensives either between 6:00 and 10:00 in the morning (10,601 people) or between 20:00 and midnight (10,503 people). Mean age at entry was 65.1 years. Median follow-up was 5.2 years.

The primary endpoint, vascular death or hospitalization for non-fatal heart attack or non-fatal stroke, occurred in:

3.4% of the evening group (0.69 events per 100 patient-years)
3.7% of the morning group (0.72 events per 100 patient-years)

The hazard ratio was 0.95, with a 95% confidence interval of 0.83 to 1.10 and a p-value of 0.53. In plain terms: no meaningful difference, and the confidence interval is narrow enough to rule out a large benefit in either direction.

What did the BedMed trials add?

TIME recruited online from a relatively motivated population. BedMed tested the same question in ordinary primary care and in a group that is usually excluded from trials.

The main BedMed trial, published in JAMA on June 17, 2025, randomized 3,357 adults with hypertension recruited through 436 Canadian primary care clinicians between 2017 and 2022. Over a median 4.6 years, the primary outcome of death or hospitalization for acute coronary syndrome, stroke, or heart failure occurred at 2.3 per 100 patient-years with bedtime dosing versus 2.4 with morning dosing. The adjusted hazard ratio was 0.96 (95% CI 0.77 to 1.19).

BedMed-Frail, published in JAMA Network Open in May 2025, ran the same comparison in 776 continuing-care residents with a median age of 88 — precisely the group where you might expect bedtime dosing to cause harm through overnight hypotension and falls. The hazard ratio was 0.88 (95% CI 0.71 to 1.11), and the trials reported no differences in unplanned hospitalizations, emergency department visits, fractures, glaucoma events, or cognitive events.

That last point is worth stating plainly, because it answers the mirror-image worry: bedtime dosing does not appear to be harmful either, even in frail older adults. This is a genuinely neutral finding, not a warning.

Does bedtime dosing lower nighttime blood pressure?

Yes, and this is the nuance that explains why the debate persisted.

The OMAN randomized clinical trial compared morning with bedtime dosing and found bedtime dosing produced a greater reduction in nocturnal blood pressure. Physiologically, the drug is doing what the chronotherapy hypothesis predicted.

It just does not change the outcomes that matter. This is a recurring pattern in cardiology: a treatment improves a measurable intermediate marker without improving the clinical endpoint. Nighttime blood pressure is strongly associated with cardiovascular risk as a marker, but lowering it by shifting the dose timing does not appear to move the underlying risk.

The practical version: if your ambulatory monitoring shows a non-dipping or reverse-dipping pattern, that is worth investigating, but the investigation should look for causes such as obstructive sleep apnea, kidney disease, or excess salt intake rather than stopping at a dose-timing change. Sleep apnea in particular is a common and treatable driver of nocturnal hypertension, and insomnia.md covers the warning signs here.

When does timing actually matter?

A handful of situations where the clock genuinely changes things, none of them about cardiovascular outcomes:

Diuretics. Hydrochlorothiazide, chlorthalidone, and furosemide increase urine output. Evening dosing commonly means waking repeatedly to urinate, which costs sleep and, in older adults, raises fall risk. Morning is the default.
Alpha-blockers. Drugs such as doxazosin can cause a pronounced drop in blood pressure on standing, especially with the first dose, so bedtime dosing is often used to reduce the risk of fainting.
Drugs that make you drowsy or lightheaded. If a medication reliably leaves you unsteady an hour after taking it, moving it to bedtime is a reasonable tolerability adjustment.
Twice-daily regimens. Spacing matters more than the specific hours. Roughly 12 hours apart keeps blood levels steadier.
Interactions with other medicines. Some drugs need separating from others by a few hours. Your pharmacist can check this in a couple of minutes.

What should you do?

The decision rule is short: pick the time you are most likely to hit every single day, then keep it.

For most people that is morning, tied to an existing routine like brushing teeth or making coffee, because morning routines are more consistent than evening ones. For people who reliably forget in the morning rush, bedtime is better. For anyone on a diuretic, morning is preferable for the reasons above.

If you want to change your timing, mention it at your next appointment or ask your pharmacist rather than switching unilaterally, mainly to avoid a doubled or skipped dose during the transition.

One practical footnote about measurement. If you change dosing time, your home readings will shift, because you are now measuring at a different point in the drug's cycle. That is expected and is not a sign the medication stopped working. Keep your measurement routine consistent, and follow the standard technique described in this guide to home monitoring.

What matters far more than timing

Dose timing is a rounding error next to the things that actually determine blood pressure control.

Taking it at all. Adherence is the single largest problem in hypertension management. A meaningful proportion of apparently treatment-resistant hypertension turns out to be missed doses. If you skip two days a week, no dosing schedule rescues that.

Being on the right drug and dose. Many people stay on a starting dose for years without escalation or a second agent. This comparison of medication classes is a useful starting point for that conversation.

Sodium, weight, alcohol, and activity. Each of these can move blood pressure by more than any plausible timing effect. The DASH dietary pattern has among the strongest evidence of any non-drug intervention.

Measuring correctly. Wrong cuff size, talking during the reading, a full bladder, or crossed legs can each shift a reading substantially. A significant share of medication decisions are made on measurement error.

If a clinician still recommends bedtime dosing for you specifically, that is not necessarily wrong, and there may be a reason particular to your regimen. It is a fair question to ask why, given the trial evidence.